| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7cb8f27d2f582cc4287d6179667582a9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S514-912 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40 |
| filingDate |
2015-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f1a0970d18be64830c932c32819a329
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0eea4c9d5495a0c62f910c9a0c2e3ec4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf7dfa00f87a79aa41433f607e8bcfeb |
| publicationDate |
2017-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20170048426-A |
| titleOfInvention |
Compositions and methods to treat vision disorders |
| abstract |
The present invention provides sterols and uses thereof for the treatment of visual impairment. In one embodiment, a composition comprising a pharmaceutically effective amount of lanosterol is used to treat and / or prevent visual disturbances in a subject. In another embodiment, a composition comprising a pharmaceutically effective amount of lanosterol is used to treat cataract or blind / damaged visual acuity in a subject. In another embodiment, a composition comprising lanosterol is used to dissolve amyloid-like fibrils of cristalline protein. |
| priorityDate |
2014-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |